Financial News
Cellectis S.A. ADR (NQ: CLLS )
2.130
+0.050
(+2.40%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 19, 2024
Add to My Watchlist
Headline News about Cellectis S.A. ADR
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](https://investorplace.com/wp-content/uploads/2019/09/deal-handshake.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/12/image27.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/03/image-tesla5.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/13/dscf0802_do_edited-2.jpg?width=1200&height=800&fit=crop)
Cellectis Touts Positive Preliminary Data From Two Leukemia Trials
December 13, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_3862.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2501.jpeg)
![](https://cdn.benzinga.com/files/images/story/2023/01/03/image26.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2021/06/Stock-crispr-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5765.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2109.jpeg)
![](https://cdn.benzinga.com/files/images/story/2022/10/10/image21.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18636.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17655.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/26/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/23/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/23/image47.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/02/biotech4.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/01/bz-pharma_8.jpg?width=1200&height=800&fit=crop)
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 01, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/01/bz-pharma_7.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_12515.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_10871.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/05/20/yesterdays_movers.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/19/mid-day_movers_image.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_12481.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_8772.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/04/27/aapharma_17.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/11/aapharma_14.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/ep_us_feature_image_1195.jpeg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.